<?xml version="1.0" encoding="UTF-8"?>
<ref id="B172-molecules-25-04036">
 <label>172.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Klumpers</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Beumer</surname>
    <given-names>T.L.</given-names>
   </name>
   <name>
    <surname>Van Hasselt</surname>
    <given-names>J.G.C.</given-names>
   </name>
   <name>
    <surname>Lipplaa</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Karger</surname>
    <given-names>L.B.</given-names>
   </name>
   <name>
    <surname>Kleinloog</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Freijer</surname>
    <given-names>J.I.</given-names>
   </name>
   <name>
    <surname>De Kam</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Van Gerven</surname>
    <given-names>J.M.A.</given-names>
   </name>
  </person-group>
  <article-title>Novel Δ9-tetrahydrocannabinol formulation Namisol
   <sup>®</sup> has beneficial pharmacokinetics and promising pharmacodynamic effects
  </article-title>
  <source>Br. J. Clin. Pharm.</source>
  <year>2011</year>
  <volume>74</volume>
  <fpage>42</fpage>
  <lpage>53</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1365-2125.2012.04164.x</pub-id>
 </element-citation>
</ref>
